The Senior Management Team
Dr Davy Yeung BSc (Hons), PhD, MBA
– Managing Director
Dr Davy Yeung’s career to date encompasses academia and the NHS. He has made valuable contributions to clinical research at the University of Cambridge, Imperial College and other major academic institutions.
Dr Yeung was also the Head of Research at various UK Hospital Trusts. During his time in the NHS, he gained considerable insight into the governance and delivery of clinical research in the UK. This unique perspective enables our sponsors to rapidly and effectively select, initiate and manage UK investigative sites for their clinical studies.
Having collaborated with a wide range of influential leaders in the field of clinical research, Dr Yeung is himself highly respected and well known in the UK’s healthcare research and development sector.
Dr Peter MacLennan BSc (Hons) PhD
– Chief Operating Officer
With over 20 years’ experience in the industry, Dr MacLennan has a unique insight into the needs of our clients, and how to put operational plans in place that will achieve their objectives rapidly, cost-effectively and to the highest standards of quality.
His principal focus is working in close partnership with organisations developing novel therapeutic agents.
Within the pharmaceutical industry he had responsibility for UK clinical trials and CRO management, and gained a keen understanding of CRO relationships from the sponsor’s perspective.
He complements this with senior level experience in CROs – most notably at ORION Clinical Services where he had a key role in the management team.
Professor Alan K Boyd BSc (Hons) MB ChB FRSB PFPM
– Consultant Medical Director
Professor Alan Boyd is a highly regarded pharmaceutical physician with expertise across all phases of drug development.
Following a career as a senior executive in major pharmaceutical companies he was appointed Head of Research and Development at Ark Therapeutics and was instrumental in their growth to become an established healthcare company.
He also had a key role in raising funds for the business in the form of venture capital and during the IPO process.
By combining expertise across a wide variety of therapeutic areas with in-depth knowledge of the investment community’s requirements, he is ideally placed to support our sponsors in planning and implementing their clinical development programmes.
Professor Boyd was elected President of the Faculty of Pharmaceutical Medicine in November 2015.
Lucy Parker BSocSc
– Director of Regulatory Affairs
Lucy Parker is responsible for Regulatory Affairs and Research Governance at TCRS – she brings many years experience of conducting regulatory submissions for clinical trial approvals.
This includes the submission of documentation to REC/IRBs and negotiation with hospitals to obtain R and D approval.
The majority of this experience has been gained within major London Teaching hospitals giving Lucy a particularly strong perspective on the key success factors for dealing with large, complex UK institutions. It also means that she is ideally qualified to navigate through the new HRA process for study approval within the UK.
This skillset enables the TCRS team to submit documentation to the MHRA and achieve start-up of UK sites in a rapid, efficient and cost-effective manner.